Greenleaf Trust lifted its stake in Centene Co. (NYSE:CNC – Free Report) by 7.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,384 shares of the company’s stock after buying an additional 566 shares during the period. Greenleaf Trust’s holdings in Centene were worth $622,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Turtle Creek Wealth Advisors LLC bought a new stake in shares of Centene in the fourth quarter valued at approximately $25,000. Operose Advisors LLC acquired a new position in shares of Centene during the third quarter worth $25,000. OFI Invest Asset Management acquired a new stake in Centene in the third quarter valued at $26,000. Headinvest LLC bought a new position in shares of Centene in the 3rd quarter worth about $35,000. Finally, Provence Wealth Management Group acquired a new stake in shares of Centene in the 3rd quarter valued at about $44,000. 93.63% of the stock is currently owned by institutional investors.
Insider Activity
In related news, Director Lori Jean Robinson sold 10,000 shares of the stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now directly owns 11,455 shares of the company’s stock, valued at $886,731.55. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Centene news, President Kenneth J. Fasola sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the transaction, the president now owns 235,365 shares of the company’s stock, valued at $17,668,850.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lori Jean Robinson sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now directly owns 11,455 shares of the company’s stock, valued at approximately $886,731.55. The disclosure for this sale can be found here. Insiders own 0.29% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on Centene
Centene Stock Up 0.6 %
Shares of NYSE:CNC opened at $75.59 on Tuesday. Centene Co. has a 52-week low of $60.83 and a 52-week high of $81.42. The firm has a fifty day moving average of $76.51 and a 200 day moving average of $74.70. The firm has a market capitalization of $40.43 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 0.93 and a beta of 0.38. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.11 and a current ratio of 1.11.
Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Centene had a net margin of 1.75% and a return on equity of 14.26%. The business had revenue of $39.46 billion during the quarter, compared to analyst estimates of $36.16 billion. During the same period in the prior year, the business posted $0.86 earnings per share. The company’s revenue was up 11.0% on a year-over-year basis. As a group, research analysts anticipate that Centene Co. will post 6.75 EPS for the current fiscal year.
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories
- Five stocks we like better than Centene
- Why is the Ex-Dividend Date Significant to Investors?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- What Are Growth Stocks and Investing in Them
- Merger or Not, Albertson’s Companies is a Good Buy
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Cheap Stocks That Shouldn’t Be So
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.